It seems to implicate a biphasic mediator in its pathogenesis; that is, hyperadiponectinemia may protect against systemic atherosclerosis but drive cytokine production from affected joints, resulting in body weight loss followed by additional secretion of circulating adiponectin (Fig 2). This evidence concerns the gene ADIPOQ and atherosclerosis.